Clinical trials: Retinal Vascular Disorder, open to volunteers

Diabetic Macular Edema (DME), Age-Related Macular Degeneration (AMD)

Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections

• Enrolling by invitation
• Age: 18 years and older
• Phase 4
• Injection or infusion

This Phase 4, multicenter, randomized, double-masked clinical study evaluates the efficacy and safety of chloroprocaine hydrochloride ophthalmic gel 3% (IHEEZO) compared with routine anesthesia (topical proparacaine 0.5% combined…

Conditions

Diabetic Macular Edema (DME), Age-Related Macular Degeneration (AMD), Retinal Vein Occlusion, Diabetic Retinopathy (DR)

Trial name

Quell (NCT07456826)

Testing

Chloroprocaine Ophthalmic Gel 3% (IHEEZO), Proparacaine Hydrochloride Ophthalmic Solution 0.5%, Lidocaine Hydrochloride Injection 2%

Where

United States

Volunteers

236 people

Sponsor

Harrow Inc